Caredx to participate in upcoming investor conferences

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) — the transplant company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences. craig-hallum 22nd annual institutional investor conference in minneapolis, mn on wednesday, may 28. jefferies global health.
CDNA Ratings Summary
CDNA Quant Ranking